CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Silymarin is a potent antiviral drug against HCV in nonresponders to Peginterferon/Ribavirin – Dose finding and viral kinetics studies
DOI 10.1055/s-2008-1081508
Bibliografische Angaben
Nachweis in CareLit
Autor:innenTM Scherzer, K Rutter, S Beinhardt, H Kerschner, H Hofer, M Schöniger-Hekele, P Steindl-Munda, P Ferenci
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe06/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Silibinin (SIL) is the main flavonoid extracted from milk thistle (Silibum marianum G.). By chance we detected that iv. SIL is a potent antiviral compound in patients with chronic hepatitis C not responding to standard antiviral therapy. In this study the optimal dose of SIL was investigated. Furthermore the viral kinetics were studied. For dose finding different dosages of intravenous Silibinin (Legalon…
Zitieren
Zitierempfehlung
TM Scherzer, K Rutter, S Beinhardt, H Kerschner, H Hofer, M Schöniger-Hekele, P Steindl-Munda, P Ferenci (2008) Silymarin is a potent antiviral drug against HCV in nonresponders to Peginterferon/Ribavirin – Dose finding and viral kinetics studies. Zeitschrift für Gastroenterologie (06). https://doi.org/10.1055/s-2008-1081508
Mit CareLit weiterarbeiten